Hematopoietic Growth Factors in the Supportive Care and Treatment of Patients with Hematologic Neoplasms

2012 ◽  
pp. 1347-1361
Author(s):  
Belinda R. Avalos ◽  
Edward A. Copelan
Keyword(s):  
Growth Factors ◽  
Supportive Care ◽  
Hematologic Neoplasms ◽  
Hematopoietic Growth Factors ◽  
Care And Treatment

scholarly journals NCCN Guidelines Insights: Hematopoietic Growth Factors, Version 1.2020

2020 ◽  
Vol 18 (1) ◽  
pp. 12-22 ◽  
Author(s):  
Pamela Sue Becker ◽  
Elizabeth A. Griffiths ◽  
Laura M. Alwan ◽  
Kimo Bachiashvili ◽  
Anna Brown ◽  
...  
Keyword(s):  
Growth Factors ◽  
Febrile Neutropenia ◽  
Supportive Care ◽  
Granulocyte Colony Stimulating Factor ◽  
Colony Stimulating Factor ◽  
Hematopoietic Growth Factors ◽  
Appropriate Use ◽  
Nccn Guidelines ◽  
Prevention And Treatment ◽  
Stimulating Factor

Management of febrile neutropenia (FN) is an integral part of supportive care for patients undergoing cancer treatment. The NCCN Guidelines for Hematopoietic Growth Factors provide suggestions for appropriate evaluation, risk determination, prophylaxis, and management of FN. These NCCN Guidelines are intended to guide clinicians in the appropriate use of growth factors for select patients undergoing treatment of nonmyeloid malignancies. These NCCN Guidelines Insights highlight important updates to the NCCN Guidelines regarding the incorporation of newly FDA-approved granulocyte-colony stimulating factor biosimilars for the prevention and treatment of FN.

Impaired expression of hematopoietic growth factors: A candidate mechanism for the hematopoietic defect of aging

1996 ◽  
Vol 31 (1-2) ◽  
pp. 135-144 ◽  
Author(s):  
J.P. Buchanan ◽  
C.A. Peters ◽  
C.J. Rasmussen ◽  
G. Rothstein
Keyword(s):  
Growth Factors ◽  
Hematopoietic Growth Factors
Sign in / Sign up

Export Citation Format

Share Document